ASCO 2022 Updates in HR+/HER2- eBC


 

ASCO 2022 on ABCSG-18 Trial: Long-Term Outcomes of Adjuvant Denosumab in Breast Cancer: Fracture Reduction & Survival Results

1,003 views
June 9, 2022
3 Comments
Login to view comments. Click here to Login
ASCO 2022 Updates in HR+/HER2- eBC